ŞİMŞEK, T. Et Al. 2020. Treatment of Neovascular Glaucoma with Transscleral Diod Laser Cyclophotocoagulatıon Alone Versus Combination of Intravitreal Bevacizumab and Transscleral Diod Laser Cyclophotocoagulation. 14th EGS Congress .

ŞİMŞEK, T., YAŞAR, M., ATALAY, E., ÖZALP, O., & YILDIRIM, N., (2020). Treatment of Neovascular Glaucoma with Transscleral Diod Laser Cyclophotocoagulatıon Alone Versus Combination of Intravitreal Bevacizumab and Transscleral Diod Laser Cyclophotocoagulation . 14th EGS Congress

ŞİMŞEK, TÜLAY Et Al. "Treatment of Neovascular Glaucoma with Transscleral Diod Laser Cyclophotocoagulatıon Alone Versus Combination of Intravitreal Bevacizumab and Transscleral Diod Laser Cyclophotocoagulation," 14th EGS Congress, 2020

ŞİMŞEK, TÜLAY Et Al. "Treatment of Neovascular Glaucoma with Transscleral Diod Laser Cyclophotocoagulatıon Alone Versus Combination of Intravitreal Bevacizumab and Transscleral Diod Laser Cyclophotocoagulation." 14th EGS Congress , 2020

ŞİMŞEK, T. Et Al. (2020) . "Treatment of Neovascular Glaucoma with Transscleral Diod Laser Cyclophotocoagulatıon Alone Versus Combination of Intravitreal Bevacizumab and Transscleral Diod Laser Cyclophotocoagulation." 14th EGS Congress .

@conferencepaper{conferencepaper, author={TÜLAY ŞİMŞEK Et Al. }, title={Treatment of Neovascular Glaucoma with Transscleral Diod Laser Cyclophotocoagulatıon Alone Versus Combination of Intravitreal Bevacizumab and Transscleral Diod Laser Cyclophotocoagulation}, congress name={14th EGS Congress}, city={}, country={}, year={2020}}